JNJ-42153605 | Interleukin Related interleukin-related.com

Product Name :
JNJ-42153605

Search keywords :
JNJ-42153605

drugId :
null

Target Vo:
Metabotropic glutamate receptor 2

Target Vo Short Name :
GRM2

Moa_Name:

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Johnson & Johnson

Active Company_Name :
Johnson & Johnson

Active Indication_Name:
Psychotic Disorders

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Ofatumumab CD20
Bapineuzumab supplier
DNA-PKcs/PRKDC Antibody: DNA-PKcs/PRKDC Antibody is a non-conjugated and Mouse origined monoclonal antibody about 469 kDa, targeting to DNA-PKcs/PRKDC. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts